Impact of phytolacca Americana extracts on gene expression of colon cancer cells

Phytotherapy Research

Volumn 28, Issue 2, 2014, Pages 219-223

  Maness, L ^a   Goktepe, I ^a,c   Chen, H ^b   Ahmedna, M ^b   Sang, S ^b  

^a North Carolina Agricultural and Technical   (United States)

^b North Carolina Research Campus   (United States)

^c Department of Biological and Environmental Sciences ^*  (Qatar)

Author keywords

antiproliferative activity; HCT 116 Colon Cancer Cells; Human Cancer Pathway Finder; Phytolacca americana

Indexed keywords

ANTIPROLIFERATIVE ACTIVITY; HCT-116 COLON CANCER CELLS; HUMAN CANCER PATHWAY FINDER; PHYTOLACCA AMERICANA;

COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; PHYTOLACCA AMERICANA; PLANT EXTRACTS; PLANT ROOTS;

EID: 84893774484     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4979     Document Type: Article

References (29)

1. ACS, 2009. Cancer statistics 2009 presentation. http://www.cancer.org/ Research/CancerFactsFigures/cancer-statistics-2009-presentation
2. Albini A, Marchisone C, Marchisone C, et al,. 2000. Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: a gene therapy approach. Am J Pathol 156: 1381-1393.
3. Botchkina I, Rowehl R, Rivadeneira D, et al,. 2009. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis. Cancer Genomics Proteomics 6: 19-29.
4. Cho M, Gwak J, Park S, et al,. 2005. Diclofenac attenuates WNT/β-catenin signaling in colon cancer cells by activation of NF-κB. FEBS Lett 579: 4213-4218.
5. Dales J, Garcia S, Carpentier S, et al,. 2004. Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, TIE-2//TEK and CD105 expression in breast cancer (n = 905). Brit J Cancer 90: 1216-1221.
6. Datta S, Dudek H, Tao X, et al,. 1997. AKT phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231-241.
7. Dixon D, Moyana T, King M,. 1998. Elevated expression of the CDC25A protein phosphatase in colon cancer. Exp Cell Res 240: 236-243.
8. Firestein R, Bass A, Kim S, et al,. 2008. CDK8 is a colorectal cancer oncogene that regulates β-catenin activity. Nature 455: 547-551.
9. Galaktionov K, Lee A, Eckstein J, et al,. 1995. CDC25 phosphatases as potential human oncogenes. Science 269: 1575-1577.
10. Jiang M, Milner J,. 2003. BCL2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells. Gene Dev 17: 832-837.
11. Jones E,. 2006. Cancer: Its Causes, Symptoms, and Treatment. Healing Mountain Publishing, Washington. ISBN 0974117854.
12. Kandel E, Skeen J, Majewski N, et al,. 2002. Activation of AKT/protein kinase B overcomes a G2/M cell cycle checkpoint induced by DNA damage. Mol Cell Biol 22: 7831-7841.
13. Kasahara M, Takahashi Y, Nagata T, et al,. 2000. Thymidylate synthase expression correlates closely with E2F1 expression in colon cancer. Clin Cancer Res 6: 2707-2711.
14. Kracmarova A, Cermak J, Brdicka R, Bruchova A,. 2008. High expression of ERCC1, FLT1, NME4 and PCNA associated with poor prognosis and advanced stages in myelodysplastic syndrome. Leuk Lymphoma 49: 1297-1305.
15. Louie M, Zou J, Rabinovich A, Chen H,. 2004. ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance. Mol Cell Biol 24: 5157-5171.
16. Maness L, Goktepe I, Hardy B, Yu J, Ahmedna M,. 2012. Antiproliferative and Apoptotic Effects of Phytolacca Americana Extracts and their Fractions on Breast and Colon Cancer Cells. Res J Med Plants 6: 17-26.
17. Nevins J,. 2001. The RB/E2F pathway and cancer. Hum Mol Genet 10: 699-703.
18. Park W, Park J, Oh R, et al,. 2000. A distinct tumor suppressor gene locus on chromosome 15q21.1 in sporadic form of colorectal cancer. Cancer Res 60: 70-73.
19. 2-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13: 272-286.
20. Ploug M, Gardsvoll H, Jorgensen T, Lonborg Hansen L, Dano K,. 2002. Structural analysis of the interaction between urokinase-type plasminogen activator and its receptor: a potential target for anti-invasive cancer therapy. Biochem Soc T 30: 177-183.
21. Samowitz W, Slattery M, Sweeney C, Herrick J, Wolff R, Albertsen H,. 2007. APC mutations and other genetic and epigenetic changes in colon cancer. Mol Cancer Res 5: 165-170.
22. Schlick J, Dulieu P, Desvoyes B, Adami P, Radom J, Jouvenot M,. 2000. Cytotoxic activity of a recombinant GnRH-PAP fusion toxin on human tumor cell lines. FEBS Lett 472: 241-246.
23. Stopera S, Davie J, Bird R,. 1992. Colonic aberrant crypt foci are associated with increased expression of C-FOS: the possible role of modified C-FOS expression in preneoplastic lesions in colon cancer. Carcinogenesis 13: 573-578.
24. Pfaffl M., 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
25. Poincloux L, Durando X, Seitz J, et al,. 2009. Loss of Bcl-2 expression in colon cancer: A prognostic factor for recurrence in stage II colon cancer. Surg Oncol 18: 357-365.
26. Takahashi H, Namikawa Y, Tanaka M, Fukuyama Y,. 2001. Triterpene glycosides from the cultures of Phytolacca americana. Chem Pharm Bull 49: 246-248.
27. Tokunaga T, Tsuchida T, Kijima H, et al,. 2000. Ribozyme-mediated inactivation of mutant K-ras oncogene in a colon cancer cell line. Brit J Cancer 83: 833-839.
28. Wang C, Mayo M, Korneluk R, Goeddel D, Baldwin S,. 1998. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and C-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 281: 1680-1683.
29. Zarling J, Moran P, Haffar O, Sias J, Richman D,. 1990. Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies. Nature 347: 92-95.